![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
SGLT2 Inhibitors in Chronic Kidney Disease (Harvard Medical School Continuing Education) View |
![]() |
SGLT2 Inhibitor trials - SUMMARY (Dr Manoj Prabhakaran MD DM) View |
![]() |
SGLT2 Inhibitors: CV Outcomes Data in Type 2 Diabetes (HCPLive) View |
![]() |
Trials with SGLT Inhibitors (Santhosh Karikkad) View |
![]() |
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond - summary presentation (At the Limits - Leading Medical Education) View |
![]() |
Update on SGLT-2 inhibitors (ADA 2021) (GoggleDocs Education) View |
![]() |
Current CV Evidence Across SGLT2 Inhibitors (HCPLive) View |
![]() |
Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment (Medscape) View |
![]() |
Using SGLT2-inhibitors to treat cardiac patients with diabetes (Ted Rogers Centre for Heart Research) View |
![]() |
Silvio Inzucchi, MD: Implications of Initial EGFR Response to Empagliflozin (HCPLive) View |